| |
| |
| Exchange: |
OTC Bulletin Board |
| Security
Type: |
Common |
| Shares
Out: |
26,320,000 |
| Market
Cap: |
3.83(M) |
| Last
Volume: |
169,426 |
Avg
Vol: |
168,958 |
| 52
Week Range: |
$0.1454 - $0.1454 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Related Products |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Navidea Biopharmaceuticals is a biopharmaceutical company focused on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. Co. is developing multiple precision-targeted products based on its Manocept™ platform to improve patient care by identifying the sites and pathways of undetected disease and enable diagnostic, clinical decision-making and targeted treatment. Co.'s business is focused on two primary types of drug products: diagnostic substances, including Tc99m tilmanocept and other diagnostic applications of its Manocept platform; and therapeutic development programs, including therapeutic applications of its Manocept platform.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-15 |
2023-11-14 |
2023-05-16 |
2022-05-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Rice Yehuda Michael |
Director |
• • – |
2019-02-07 |
4 |
A |
$0.00 |
$50 |
D/D |
50,000 |
150,000 |
|
- |
|
| Cutler Adam D. |
Director |
• • – |
2019-02-07 |
4 |
A |
$0.00 |
$50 |
D/D |
50,000 |
100,000 |
|
- |
|
| Rouan Sarah Kathryn |
Director |
• • – |
2019-02-07 |
4 |
A |
$0.00 |
$50 |
D/D |
50,000 |
100,000 |
|
- |
|
| Bruck Claudine |
Director |
• • – |
2019-02-07 |
4 |
A |
$0.00 |
$50 |
D/D |
50,000 |
100,000 |
|
- |
|
| Cutler Adam D. |
Director |
• • – |
2019-01-02 |
4 |
A |
$0.00 |
$50 |
D/D |
50,000 |
50,000 |
|
- |
|
| Rouan Sarah Kathryn |
Director |
• • – |
2019-01-02 |
4 |
A |
$0.00 |
$50 |
D/D |
50,000 |
50,000 |
|
- |
|
| Cope Frederick O |
SVP & CSO |
• • – |
2018-06-29 |
4 |
A |
$0.23 |
$48,850 |
D/D |
212,390 |
585,052 |
|
- |
|
| Bruck Claudine |
Director |
• • – |
2018-03-15 |
4 |
A |
$0.00 |
$50 |
D/D |
50,000 |
50,000 |
|
- |
|
| Cope Frederick O |
SVP & CSO |
• • – |
2018-02-20 |
4 |
A |
$0.36 |
$48,850 |
D/D |
135,694 |
372,662 |
|
- |
|
| Greene Mark I |
Director |
• • – |
2018-02-20 |
4 |
A |
$0.00 |
$50 |
D/D |
50,000 |
157,244 |
|
- |
|
| Rowinsky Eric K |
Director |
• • – |
2018-02-20 |
4 |
A |
$0.00 |
$50 |
D/D |
50,000 |
341,446 |
|
- |
|
| Rice Yehuda Michael |
Director |
• • – |
2018-02-20 |
4 |
A |
$0.00 |
$50 |
D/D |
50,000 |
100,000 |
|
- |
|
| Rice Yehuda Michael |
Director |
• • – |
2017-09-14 |
4 |
GD |
$0.00 |
$0 |
D/D |
28,000 |
50,000 |
|
- |
|
| Rowinsky Eric K |
Director |
• • – |
2017-06-30 |
4 |
A |
$0.00 |
$50 |
D/D |
50,000 |
291,446 |
|
- |
|
| Rice Yehuda Michael |
Director |
• • – |
2017-06-30 |
4 |
A |
$0.00 |
$50 |
D/D |
50,000 |
78,000 |
|
- |
|
| Fiorino Anthony S. |
Director |
• • – |
2017-06-30 |
4 |
A |
$0.00 |
$50 |
D/D |
50,000 |
78,000 |
|
- |
|
| Greene Mark I |
Director |
• • – |
2017-06-30 |
4 |
A |
$0.00 |
$50 |
D/D |
50,000 |
107,244 |
|
- |
|
| Regan William J. |
SVP & CCO |
• • – |
2017-06-29 |
4 |
B |
$0.53 |
$10,586 |
D/D |
20,000 |
172,977 |
2.74 |
- |
|
| Latkin Jed |
COO and CFO |
• – – |
2017-05-30 |
4 |
B |
$0.44 |
$3,317 |
D/D |
7,600 |
50,159 |
0.01 |
- |
|
| Latkin Jed |
COO and CFO |
• – – |
2017-05-22 |
4 |
B |
$0.45 |
$5,039 |
D/D |
11,200 |
42,559 |
0.01 |
- |
|
| Latkin Jed |
COO and CFO |
• – – |
2017-05-19 |
4 |
B |
$0.45 |
$6,387 |
D/D |
14,159 |
31,359 |
0.01 |
- |
|
| Latkin Jed |
COO and CFO |
• – – |
2017-05-18 |
4 |
A |
$0.45 |
$1,753 |
D/D |
3,900 |
17,200 |
|
- |
|
| Latkin Jed |
COO and CFO |
• – – |
2017-05-17 |
4 |
A |
$0.47 |
$6,211 |
D/D |
13,300 |
13,300 |
|
- |
|
| Goldberg Michael M |
President & CEO |
• • – |
2017-05-16 |
4 |
A |
$0.46 |
$48,759 |
D/D |
106,021 |
5,921,023 |
|
- |
|
| Cope Frederick O |
SVP & Chief Scientific Officer |
• – – |
2017-02-06 |
4 |
A |
$0.52 |
$45,957 |
D/D |
88,378 |
180,593 |
|
- |
|
192 Records found
|
|
Page 5 of 8 |
|
|
